Tuva Health vs GE HealthCare
Side-by-side comparison of AI visibility scores, market position, and capabilities
NY open-source healthcare claims data transformation platform serving 1,500+ practitioners at Oscar Health and MultiCare; YC W22 $6M Virtue-backed first health system-backed open-source data platform competing with Datavant for healthcare analytics engineering.
About
Tuva Health is a New York-based open-source healthcare data transformation company — backed by Y Combinator (W22) with $6 million raised including a $5 million seed round in December 2024 led by Virtue with Box Group, YC, and health technology angels, plus MultiCare Capital Partners (investment from MultiCare Health System making Tuva the first open-source data platform backed by a health system) in February 2025 — operating the Tuva Project, the world's first open-source healthcare data transformation platform that enables payers, providers, and pharmaceutical companies to convert raw claims and EHR datasets into analytics-ready data models through built-in normalization, quality testing, and clinical enrichment. Tuva serves 1,500+ healthcare data practitioners and 30+ partners including Oscar Health and MultiCare.
Chicago medical imaging and AI diagnostics (NASDAQ: GEHC) ~$19.7B FY2024 revenue; GE spinoff Jan 2023, Edison AI 100+ models, 4M+ installed devices, Alzheimer's PET tracer competing with Siemens Healthineers.
About
GE HealthCare Technologies Inc. is a Chicago, Illinois-based medical technology and digital health company — publicly traded on the NASDAQ (NASDAQ: GEHC) as an S&P 500 Health Care component — designing, manufacturing, and servicing medical imaging systems, patient monitoring equipment, pharmaceutical diagnostics, and AI-powered clinical decision support software through approximately 51,000 employees in 160 countries. GE HealthCare was spun off from General Electric Company in January 2023 — one of the most significant healthcare demergers in history — and has operated as an independent public company building its own capital structure, R&D investment priorities, and operational identity separate from GE's industrial conglomerate structure. In fiscal year 2024, GE HealthCare reported revenues of approximately $19.7 billion, with its four business segments contributing: Imaging (MRI, CT, X-ray, molecular imaging — ~$9.1B), Ultrasound (~$3.0B), Patient Care Solutions (monitoring, anesthesia — ~$3.6B), and Pharmaceutical Diagnostics (PET/SPECT contrast agents — ~$2.6B). CEO Peter Arduini has prioritized accelerating GE HealthCare's AI integration across its imaging portfolio — the Edison AI platform (100+ AI models cleared or in development for radiology workflows) embeds AI-assisted detection, workflow optimization, and image quality enhancement into GE HealthCare scanners, positioning the company as a digital health platform rather than a hardware manufacturer.
AI Visibility Head-to-Head
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.